Citicoline Dosage: 250 mg, 500 mg or More?

Citicoline dosage: what the research actually used

The oral citicoline trials in healthy people used 250 mg or 500 mg a day: 250 or 500 mg for 28 days in adolescent boys, and 500 mg a day for 12 weeks in older adults with age-associated memory complaints. No trial has shown that taking more than 500 mg a day by mouth gives healthy adults a greater cognitive effect. That is an absence of evidence rather than a proven ceiling — higher oral doses have simply not been tested for cognition in healthy people. Much larger doses appear in hospital stroke and brain-injury research, which is a different context with disappointing results.

This guide walks through what each trial used, what it found, and how citicoline compares with other choline sources.

The dose-response picture

• Adolescent males, 250 or 500 mg a day for 28 days (McGlade et al., 2019): 75 healthy boys were randomised to citicoline (Cognizin) or placebo. The citicoline group improved more on attention and psychomotor speed, and a higher dose per kilogram of body weight predicted better attention accuracy and lower impulsivity — so within this range, more was associated with more, not less.
• Older adults, 500 mg a day for 12 weeks (Nakazaki et al., 2021): 100 healthy men and women aged 50 to 85 with age-associated memory impairment. Episodic memory and a composite memory score, both secondary outcomes, improved more than with placebo.
• 500 mg versus 2,000 mg a day for six weeks (Silveri et al., 2008): 16 healthy adults. This measured brain energy and membrane chemistry by magnetic resonance spectroscopy, not cognition, and the changes tended to be larger at the lower dose.
• Hospital doses: in the ICTUS stroke trial, patients received 2,000 mg a day (intravenous, then oral) for six weeks, and there was no difference from placebo at 90 days. The Linus Pauling Institute summarises the stroke evidence as offering little support for benefit.

The branded ingredient Cognizin was used in the first three studies above, so it is the form with the most direct link to the healthy-adult data.

Dosage by goal

Those two supplement-range doses are the ones used on this site: 250 mg in the Focus & Flow stack, the lower dose from the adolescent trial, and 500 mg in the Executive Performance stack, the dose from the memory-impairment trial.

Timing and splitting the dose

No trial compared morning with evening dosing or one dose with two. Because the effects reported in the trials built up over weeks rather than appearing within hours, the time of day is mainly a matter of convenience. The ICTUS stroke trial gave its oral doses 12 hours apart, and splitting 500 mg into two 250 mg doses is a reasonable default if one dose disagrees with you.

Comparing citicoline to alpha-GPC dosing

By molecular weight, choline makes up about 21% of citicoline (104.17 of 488.32) and about 40% of alpha-GPC (104.17 of 257.22). So 500 mg of citicoline supplies roughly 107 mg of choline, while the same weight of alpha-GPC supplies roughly 200 mg — which is why the two compounds cannot be compared milligram for milligram. Citicoline also supplies cytidine. For the full comparison, including taking both, seealpha-GPC vs CDP-choline, and for ingredient summaries seeciticoline andalpha-GPC.

A simple titration protocol

1. Start at 250 mg a day for a week to check tolerance.
2. If you want to match the longer trial, move to 500 mg a day (for example 250 mg twice daily).
3. Track a specific, consistent marker — a short task you repeat, or a daily focus rating — rather than relying on a vague sense of how you feel.
4. Judge it at around the length of the relevant trial: four weeks for attention, twelve for memory.
5. If nothing has changed, stop rather than escalating; there is no evidence that doses above 500 mg help healthy adults.
6. If you notice side effects, reduce the dose or stop.

Side effects and who should be cautious

A Cochrane review of CDP-choline in older people described it as well tolerated. In a drug-surveillance study of 4,191 stroke patients taking 500 to 4,000 mg a day by mouth, side effects were reported in 31 people (0.73%), most often nervous-system symptoms followed by gastrointestinal ones. Those figures come from patients, not healthy supplement users, and long-term use by healthy adults has not been studied beyond a few months.

Citicoline adds to your total choline intake, although at 500 mg a day it supplies only around 107 mg of choline against an adult upper limit of 3,500 mg a day. The debate about choline, gut bacteria and the metabolite TMAO is covered incholine sources for brain health. The Cochrane review notes that citicoline affects adrenergic and dopaminergic activity in the brain and has been used as an add-on treatment in Parkinson's disease, so if you take prescription medication — particularly for Parkinson's disease or dementia — check with your doctor or pharmacist before starting it.

When to speak to a clinician

Most of the evidence for meaningful clinical benefit comes from older adults or people with vascular or age-related cognitive problems, and even there the Cochrane review found benefit for memory and behaviour but not for attention. The healthy-adult evidence rests on two small trials. If you are considering citicoline for a medical reason rather than general interest, that decision belongs with a clinician, not a dosing guide.

Key takeaways

• The healthy-adult trials used 250–500 mg a day by mouth for four to twelve weeks.
• No study shows a greater cognitive effect above 500 mg a day in healthy adults; the only higher-dose comparison measured brain chemistry, not cognition.
• Gram-range doses belong to stroke research, where the large trial found no benefit.
• Citicoline is about 21% choline by weight, alpha-GPC about 40%.
• It was well tolerated in the reviewed studies; check with a clinician if you take prescription medication.

Common questions

Is 500 mg of citicoline safe to take daily?

500 mg a day was the dose used for 12 weeks in healthy older adults, and the Cochrane review described citicoline as well tolerated. Anyone with a medical condition or taking prescription medication should confirm with a clinician first.

Does citicoline need to be cycled?

No study has tested cycling. The healthy-adult trials ran for four to twelve weeks, so there is little data on continuous use beyond that; reassessing every few months is a sensible precaution rather than an evidence-based rule.

What's the difference between citicoline and Cognizin?

Cognizin is a branded form of citicoline. It was the form used in the healthy-adult trials above; the underlying compound is the same.

How much citicoline is in Mind Lab Pro?

The current Mind Lab Pro label (v4, checked 30 September 2026) lists 250 mg of citicoline as Cognizin per two-capsule serving, alongside other ingredients and no caffeine — half the 500 mg used in the 12-week memory trial. See ourMind Lab Pro review orcheck the current Mind Lab Pro label (affiliate link).

Reading a bottle correctly

Look for the milligram figure of citicoline per serving rather than a proprietary blend total, and check the serving size in capsules, since two-capsule servings change the arithmetic. If a product bundles citicoline into a blend with a single combined weight, you cannot tell whether it reaches the 250 mg used in the lowest-dose trial, which undermines the reason to choose it. A label that names Cognizin gives you the most direct link to the studied material.

Interactions and practical caveats

Because citicoline releases choline, the building block of the neurotransmitter acetylcholine, flag it alongside any other choline source or cholinergic supplement you take, such as alpha-GPC or huperzine A, and any prescription cholinesterase inhibitor used in dementia care — stacking several without advice adds up your total and makes it harder to tell what is causing any effect. As with most supplements in this category, the useful dose is set by what the trials used, and taking more than that has no evidence behind it.